{"DataElement":{"publicId":"3436564","version":"2","preferredName":"Prostate Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Regional Lymph Node N Stage","preferredDefinition":"Extent of the regional lymph node involvement for the prostate carcinoma based on evidence obtained from pathologic examination through completion of definitive surgery.","longName":"2188819v1.0:3436536v1.1","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2188819","version":"1","preferredName":"Prostate Tumor Pathologic N Stage","preferredDefinition":"Information related to pathologic N stage for prostate tumor.","longName":"PRS_TUMOR_P_N","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206573","version":"1","preferredName":"Prostate Neoplasm","preferredDefinition":"A gland in the male reproductive system just below the bladder. It surrounds part of the urethra, the canal that empties the bladder. It produces a fluid that forms part of semen. (NCI-GLOSS):(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12410:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FA7A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428379","version":"1","preferredName":"Pathologic N Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25610:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-084E-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E56866E3-4FCD-5B08-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-01","modifiedBy":"TAYLORT","dateModified":"2017-09-13","changeDescription":"9/13/17 tt transferred context; changed def - 1st letter upper case; changed Reg Status to Qualified. Updated to use Property based on NCIt concept","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3436536","version":"1.1","preferredName":"Prostate Cancer American Joint Committee on Cancer Edition 7 Pathologic N Stage","preferredDefinition":"A pathologic finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v7 classification system.  (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body._","longName":"3436536v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pN1","valueDescription":"Prostate Cancer pN1 TNM Finding","ValueMeaning":{"publicId":"2924353","version":"1","preferredName":"Prostate Cancer pN1 TNM Finding","longName":"2924353","preferredDefinition":"Prostate cancer with involvement of regional lymph nodes. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pN1 TNM Finding v6 and v7","conceptCode":"C48245","definition":"Prostate cancer with metastases in regional node(s).  (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FCB3DDF-8271-F24C-E040-BB89AD432006","latestVersionIndicator":"Yes","beginDate":"2009-07-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D69227DB-BAE8-90BE-E040-BB89AD433DCB","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"ONEDATA","dateModified":"2013-02-25","deletedIndicator":"No"},{"value":"pN0","valueDescription":"Prostate Cancer pN0 TNM Finding","ValueMeaning":{"publicId":"3351846","version":"1","preferredName":"Prostate Cancer pN0 TNM Finding","longName":"3351846","preferredDefinition":"Prostate cancer with no positive regional nodes. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pN0 TNM Finding v6 and v7","conceptCode":"C48244","definition":"Prostate cancer with no positive regional nodes. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B66D065F-1815-4C96-E040-BB89AD437AF5","latestVersionIndicator":"Yes","beginDate":"2012-01-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D69227DB-BAD4-90BE-E040-BB89AD433DCB","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"ONEDATA","dateModified":"2013-02-25","deletedIndicator":"No"},{"value":"pNX","valueDescription":"Prostate Cancer pNX TNM Finding","ValueMeaning":{"publicId":"3436538","version":"1","preferredName":"Prostate Cancer pNX TNM Finding","longName":"3436538","preferredDefinition":"Prostate cancer in which the regional lymph nodes were not sampled. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer pNX TNM Finding v6 and v7","conceptCode":"C52682","definition":"Prostate cancer in which the regional lymph nodes were not sampled. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-4A14-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4BCB70BA-BC0B-6E06-E053-F662850AF53D","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-28","modifiedBy":"ONEDATA","dateModified":"2017-03-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3436535","version":"1","preferredName":"Prostate Cancer Pathologic TNM Finding v7 American Joint Committee on Cancer N Stage Stage","preferredDefinition":"A pathologic finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v7 classification system.  (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89200:C39315:C25580:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Cancer Pathologic TNM Finding v7","conceptCode":"C89200","definition":"A pathologic finding about one or more characteristics of prostate cancer, following the rules of the TNM AJCC v7 classification system.  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD6D35E8-49BE-3E47-E040-BB89AD43055E","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D69227DB-BA65-90BE-E040-BB89AD433DCB","latestVersionIndicator":"Yes","beginDate":"2013-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"COOPERM","dateModified":"2017-03-28","changeDescription":"Versioned to extend max length to 3 and add \"p\" to PVs. mc 2/25/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"10000013","version":"1","longName":"Prostate","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5506113","version":"1","longName":"Prostate","context":"MCL","ClassificationSchemeItems":[{"publicId":"5855639","version":"1","longName":"Prostate Core","context":"MCL"},{"publicId":"7781145","version":"1","longName":"Prostate PCA Pilot","context":"MCL"}]},{"publicId":"5506116","version":"1","longName":"Pathology","context":"MCL","ClassificationSchemeItems":[{"publicId":"5855643","version":"1","longName":"Prostate Pathology","context":"MCL"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000014","version":"1","longName":"Prostate","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"},{"publicId":"10000595","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001794","version":"1","longName":"Prostate PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"PROS_CAN_PATH_N_ST_AJCC7","type":"Context Short Name","context":"NRG"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"ajcc_7_prostate_pathologic_n","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Pathologic N Stage","type":"Preferred Question Text","description":"Pathologic N Stage","url":null,"context":"NCI Standards"},{"name":"MCL Path-1","type":"Alternate Question Text","description":"Pathological - N","url":null,"context":"MCL"},{"name":"MCL-PCA-prostate-1","type":"Alternate Question Text","description":"American Joint Committee on Cancer lymph node stage  code","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"prostate_v0_13aug2020.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"D69227DB-BAF2-90BE-E040-BB89AD433DCB","latestVersionIndicator":"Yes","beginDate":"2013-02-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-25","modifiedBy":"COLBERTM","dateModified":"2021-09-22","changeDescription":"9/22/21 mr Added alt name, alt def, AQT, ref doc, CSI MCL PCA prostate. Per MCL DD.   Created for CRF standard harmonization. Released per final community approval. mc 5/7/12 Versioned VD/CDE to extend max length. mc 2/25/13.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}